Adagio Therapeutics

Adagio is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses.

Rankings by

Национальный рейтинг

414th

in United States

Региональный рейтинг

470th

in North America and Caribbean

Глобальный рейтинг

1128th

worldwide

Loading startups...